AIM Tip Sheet, November 6, 2001

November 05, 2001

Annals of Internal Medicine is published by the American College of Physicians-American Society of Internal Medicine (ACP-ASIM), an organization of more than 115,000 internal medicine physicians and medical students. The following highlights are not intended to substitute for articles as sources of information. For an embargoed fax of an article, call 1-800-523-1546, ext. 2656 or 215-351-2656.

Aspirin not a substitute for colorectal cancer screening
(See attached news release. A video news release on this article will be available on November 5, with an embargo until 5 pm ET.)

Hepatitis B Virus (HBV) studies provide new information

Two reports on hepatitis B virus (HBV) infection shed new information on infection. One study looked at the results of a universal vaccination program against HBV started in Taiwan in 1984 (Article, p. 796). The study showed that the mass vaccination program has dramatically decreased both the HBV infection rate and the carrier rate. The second study followed 1,536 Alaska Natives with chronic HBV for a median of 12.5 years (Article, p. 759). This study found that about 70 percent of the carriers recovered from the infection within ten years, when measured by disappearance of a HBV viral protein in the blood.

An estimated 1.25 million people in the United States have chronic HBV infection, and an estimated 5,000 die from liver failure and liver cancer each year. The United States implemented routine vaccination of infants for HBV, an important cause of liver disease, in 1992. Today, most infections occur among older adolescents and young adults by sexual transmission. An editorial says that immunizing more infants "will ensure that future generations are protected from HBV infection and its consequences" (Editorial, p. 835). But the writer says that unless the United States institutes a nationwide program to vaccinate adults at risk for HBV, "acute disease will continue to occur and transmission of HBV will not be eliminated for decades."

Gene variations may slow progression from HIV infection to AIDS

This study showed that variations in genes (CCR5-?32 and CCR-641 alleles) were associated with decreased risk for progression from HIV infection to AIDS (Article, p. 782). Drugs that imitate the effect of these genetic variations might delay the progression of HIV infection.
-end-


American College of Physicians

Related HIV Infection Articles from Brightsurf:

Scientists pinpoint new mechanism that impacts HIV infection
A team of scientists led by Texas Biomed's Assistant Professor Smita Kulkarni, Ph.D. and Mary Carrington, Ph.D., at the Frederick National Laboratory for Cancer Research, published results of a study that pinpointed a long noncoding RNA molecule which influences a key receptor involved in HIV infection and progression of the disease.

HIV: Reprogramming cells to control infection
Following research on cohorts, scientists from the Institut Pasteur have described the characteristics of CD8 immune cells in these 'HIV controller' subjects.

USPSTF recommendation on screening for HIV infection
The US Preventive Services Task Force (USPSTF) recommends screening for HIV infection in adolescents and adults ages 15 to 65; in those younger or older at increased risk of infection; and in all pregnant people.

HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.

HIV vaccine protects non-human primates from infection
New research shows that an experimental HIV vaccine strategy works in non-human primates.

New guidelines for treatment and prevention of HIV infection in adults
Experts have updated recommendations for the use of antiretroviral drugs in the treatment and prevention of HIV infection.

Updated recommendations for treating, preventing HIV infection
A volunteer panel of experts in HIV research and patient care evaluated new data and treatments to update recommendations from the International Antiviral Society-USA for the use of antiretroviral drugs in this special communication article.

Tracking down T cell targets to tamp down HIV infection
Scientists have narrowed in on a group of gut-residing immune cells that might predispose women to increased HIV infection risk and more severe disease.

Two antibodies are better than one for preventing HIV infection
A cocktail of two broadly-neutralizing HIV-1 antibodies (bNAbs) protected primates against infection with a mixed population of HIV viruses -- conditions that mimic real-world transmission -- researchers report.

Novel approach to track HIV infection
Scientists used a novel live-cell fluorescent imaging system that allowed them for the first time to identify individual viral particles associated with HIV infection.

Read More: HIV Infection News and HIV Infection Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.